UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Number of items: 346.

A

Ala, A; Dhillon, AP; Hodgson, HJ; (2003) Role of cell adhesion molecules in leukocyte recruitment in the liver and gut. INT J EXP PATHOL , 84 (1) 1 - 16.

Allcock, RJN; Barrow, AD; Forbes, S; Beck, S; Trowsdale, J; (2003) The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44. EUR J IMMUNOL , 33 (2) 567 - 577.

Alsowmely, A; Grasso, A; Hodgson, H; Burroughs, A; Davidson, B; Quaglia, A; Dhillon, A; (2003) Life-table analysis of survival after liver transplantation for hepatocellular carcinoma: A single centre study. In: (pp. 64-).

Alvi, AJ; Clayton, H; Joshi, C; Enver, T; Ashworth, A; Vivanco, MD; Dale, TC; (2003) Functional and molecular characterisation of mammary side population cells (vol 5, pg R1, 2003). BREAST CANCER RESEARCH , 5 (1) 10.1186/bcr563.

Alvi, AJ; Clayton, H; Joshi, C; Enver, T; Ashworth, A; Vivanco, MD; Dale, TC; (2003) Functional and molecular characterisation of mammary side population cells. Breast Cancer Res , 5 (1) R1-R8.

Amadou, C; Younger, RM; Sims, S; Matthews, LH; Rogers, J; Kumanovics, A; Ziegler, A; (2003) Co-duplication of olfactory receptor and MHC class I genes in the mouse major histocompatibility complex. HUM MOL GENET , 12 (22) 3025 - 3040. 10.1093/hmg/ddg317.

Ancliff, PJ; Gale, RE; Liesner, R; Hann, I; Linch, DC; (2003) Long-term follow-up of granulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy. BRIT J HAEMATOL , 120 (4) 685 - 690.

Ancliff, PJ; Gale, RE; Linch, DC; (2003) Neutrophil elastase mutations in congenital neutropenia. Hematology , 8 (3) pp. 165-171.

Ancliff, PJ; Gale, RE; Linch, DC; (2003) Neutrophil elastase mutations in congenital neutropenia. Hematology , 8 (3) pp. 165-171. 10.1080/1024533031000107497.

Anilkumar, N; Parsons, M; Monk, R; Ng, T; Adams, JC; (2003) Interaction of fascin and protein kinase C alpha: a novel intersection in cell adhesion and motility. EMBO JOURNAL , 22 (20) pp. 5390-5402. 10.1093/emboj/cdg521.

Ardeshna, K.M.; Smith, P.; Norton, A.; Hancock, B.W.; Hoskin, P.J.; MacLennan, K.A.; Marcus, R.E.; (2003) Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. The Lancet , 362 (9383) pp. 516-522. 10.1016/S0140-6736(03)14110-4.

Ardeshna, KM; Smith, P; Norton, A; Hancock, BW; Hoskin, PJ; MacLennan, KA; Marcus, RE; (2003) Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. LANCET , 362 (9383) 516 - 522.

Arkenau, HT; Bermann, A; Rettig, K; Strohmeyer, G; Porschen, R; Arbeitsgemeinschaft Gastrointestinale Onkologie, ; (2003) 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial. Ann Oncol , 14 (3) pp. 395-399.

Arkenau, HT; Kruse, F; Jend, HH; Porschen, R; (2003) [Differential diagnosis of morbus Crohn disease: intussusception of the colon]. Z Gastroenterol , 41 (7) pp. 663-666. 10.1055/s-2003-40549.

Atalay, G; Biganzoli, L; Renard, F; Paridaens, R; Cufer, T; Coleman, R; Calvert, AH; (2003) Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials. EUR J CANCER , 39 (17) 2439 - 2449. 10.1016/S0959-8049(03)00601-4.

Atteia, A; van Lis, R; Wetterskog, D; Gutiérrez-Cirlos, EB; Ongay-Larios, L; Franzén, LG; González-Halphen, D; (2003) Structure, organization and expression of the genes encoding mitochondrial cytochrome c(1) and the Rieske iron-sulfur protein in Chlamydomonas reinhardtii. Mol Genet Genomics , 268 (5) pp. 637-644. 10.1007/s00438-002-0779-x.

B

Baker, RJ; Gerrard, G; Wickremasinghe, RG; Hoffbrand, AV; Mehta, AB; Ross, DD; Ganeshaguru, K; (2003) Expression of breast cancer resistance protein in malignant cells from patients with leukaemia. In: LEUKEMIA. (pp. 662 - 662). NATURE PUBLISHING GROUP

Baldeschi, C; Gache, Y; Rattenholl, A; Bouillé, P; Danos, O; Ortonne, JP; Bruckner-Tuderman, L; (2003) Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors. Hum Mol Genet , 12 (15) pp. 1897-1905.

Balk, J; Chew, SK; Leaver, CJ; McCabe, PF; (2003) The intermembrane space of plant mitochondria contains a DNase activity that may be involved in programmed cell death. PLANT JOURNAL , 34 (5) pp. 573-583. 10.1046/j.1365-313X.2003.01748.x.

Barnes, EJ; Abdel-Rehim, MM; Goulis, Y; Abou Ragab, M; Davies, S; Dhillon, A; Davidson, B; (2003) Applications and limitations of blood eosinophilia for the diagnosis of acute cellular rejection in liver transplantation. American Journal of Transplantation , 3 (4) pp. 432-438.

Barrie, SE; Eno-Amooquaye, E; Hardcastle, A; Platt, G; Richards, J; Bedford, D; Workman, P; (2003) High-throughput screening for the identification of small-molecule inhibitors of retinoblastoma protein phosphorylation in cells. Anal Biochem , 320 (1) pp. 66-74.

Bates, AW; (2003) "Author pays" publishing model - Not all authors will gain. BRIT MED J , 327 (7405) 53 - 53.

Bates, AW; (2003) Autopsy on a case of roberts syndrome reported in 1672: The earliest description? AM J MED GENET A , 117A (1) 92 - 96. 10.1002/ajmg.a.10864.

Bates, AW; (2003) The sooterkin dissected: the theoretical basis of animal births to human mothers in early modern Europe. Vesalius , 9 pp. 6-14.

Bates, AW; Sebire, NJ; Williams, S; Ramsay, AD; (2003) Variable antigen expression in Hepatoblastomas. In: JOURNAL OF PATHOLOGY. (pp. 42A - 42A). JOHN WILEY & SONS LTD

Beck, S; (2003) Immunogenomics: towards a digital immune system. Novartis Found Symp , 254 pp. 223-230.

Beck, S; (2003) The Human Genome Project: What we have learnt about the MHC region on chromosome 6 and its potential to Behcet's disease. ADAMANTIADES-BEHCET'S DISEASE , 528 207 - 211.

Bergamaschi, D; Gasco, M; Hiller, L; Sullivan, A; Syed, N; Trigiante, G; Yulug, I; (2003) p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell , 3 (4) pp. 387-402.

Berthoux, L; Towers, GJ; Gurer, C; Salomoni, P; Pandolfi, PP; Luban, J; (2003) As2O3 enhances retroviral reverse transcription and counteracts Ref1 antiviral activity. J VIROL , 77 (5) 3167 - 3180. 10.1128/JVI.77.5.3167-3180.2003.

Bettencourt-Dias, M; Mittnacht, S; Brockes, JP; (2003) Heterogeneous proliferative potential in regenerative adult newt cardiomyocytes. J CELL SCI , 116 (19) 4001 - 4009. 10.1242/jcs.00698.

Birtle, AJ; Freeman, A; Masters, JRW; Payne, HA; Harland, SJ; (2003) Clinical Features of Patients Who Present with Metastatic Prostate Carcinoma and Serum Prostate-Specific Antigen (PSA) Levels < 10 ng/mL: The "PSA Negative" Patients. Cancer , 98 (11) pp. 2362-2367. 10.1002/cncr.11821.

Bjedov, I; Lecointre, G; Tenaillon, O; Vaury, C; Radman, M; Taddei, F; Denamur, E; (2003) Polymorphism of genes encoding SOS polymerases in natural populations of Escherichia coli. DNA Repair (Amst) , 2 (4) pp. 417-426.

Bjedov, I; Tenaillon, O; Gérard, B; Souza, V; Denamur, E; Radman, M; Taddei, F; (2003) Stress-induced mutagenesis in bacteria. Science , 300 (5624) pp. 1404-1409. 10.1126/science.1082240.

Bogunia-Kubik, K; Natarajan, P; Brown, S; Wolley, J; Alcocer, M; Fallen, PR; Madrigal, JA; (2003) Cord blood serum affects T cells ability to produce and respond to IL-2. Cytokine , 22 (1-2) pp. 42-49.

Borthwick, NJ; Akbar, AA; Buckley, C; Pilling, D; Salmon, M; Jewell, AP; Yong, KL; (2003) Transendothelial migration confers a survival advantage to activated T lymphocytes: role of LFA-1/ICAM-1 interactions. CLIN EXP IMMUNOL , 134 (2) 246 - 252. 10.1046/j.1365-2249.2003.02298.x.

Boshoff, C; (2003) Kaposi virus scores cancer coup. NAT MED , 9 (3) 261 - 262. 10.1038/nm0303-261.

Boshoff, C; (2003) Kohn to Kaposi. NAT MED , 9 (3) 262 - 262. 10.1038/nm0303-262.

Bowles, L; Cohen, H; (2003) Inherited thrombophilias and anticoagulation in pregnancy. BEST PRACT RES CL OB , 17 (3) 471 - 489. 10.1053/S1521-6934(03)00012-9.

Boyle, P; Autier, P; Bartelink, H; Baselga, J; Boffetta, P; Burn, J; Burns, HJG; (2003) European Code Against Cancer and scientific justification: third version (2003). ANN ONCOL , 14 (7) 973 - 1005. 10.1093/annonc/mdg305.

Brada, M; Viviers, L; Abson, C; Hines, F; Britton, J; Ashley, S; Sardell, S; (2003) Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol , 14 (12) pp. 1715-1721.

Brissault, B; Kichler, A; Guis, C; Leborgne, C; Danos, O; Cheradame, H; (2003) Synthesis of linear polyethylenimine derivatives for DNA transfection. Bioconjug Chem , 14 (3) pp. 581-587. 10.1021/bc0200529.

Brooks, A; Clingan, P; Morris, D; (2003) Hepatic artery chemotherapy and colorectal liver metastases. Lancet , 361 (9370) 1742-. 10.1016/S0140-6736(03)13340-5.

Brown, SA; Yee, TT; Griffioen, A; Lee, CA; (2003) Comparative study of full-length and B-domain deleted factor VIII concentrates. HAEMOPHILIA , 9 (6) 745 - 745.

Bucheit, AD; Kumar, S; Grote, DM; Lin, YK; von Messling, V; Cattaneo, RB; Fielding, AK; (2003) An oncolytic measles virus engineered to enter cells through the CD20 antigen. MOLECULAR THERAPY , 7 (1) pp. 62-72. 10.1016/S1525-0016(02)00033-3.

Burcombe, RJ; Makris, A; Pittam, M; Finer, N; (2003) Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual. Breast , 12 (4) pp. 290-293.

C

Calabrese, CR; Batey, MA; Thomas, HD; Durkacz, BW; Wang, LZ; Kyle, S; Skalitzky, D; (2003) Identification of potent nontoxic poly(ADP-ribose) polymerase-1 inhibitors: Chemopotentiation and pharmacological studies. CLIN CANCER RES , 9 (7) 2711 - 2718.

Calvert, H; (2003) Pemetrexed (Alimta): A promising new agent for the treatment of breast cancer. SEMINARS IN ONCOLOGY , 30 (2) 2 - 5. 10.1053/sonc.2003.37267.

Camilleri, RS; Mackie, IJ; Humphries, SE; Machin, SJ; Cohen, H; (2003) Lack of association of beta 2-glycoprotein I polymorphisms Val247Leu and Trp316Ser with antiphospholipid antibodies in patients with thrombosis and pregnancy complications. BRIT J HAEMATOL , 120 (6) 1066 - 1072.

Cecilioni, L; Stigliano, R; Leandro, G; Quaglia, A; Dhillon, AP; Rolles, K; Davidson, B; (2003) Predictive factors for the absence of cellular rejection after liver transplantation in a protocol biopsy population. In: (pp. 452-).

Cecilioni, L; Stigliano, R; Leandro, G; Quaglia, A; Dhillon, AP; Rolles, K; Davidson, B; (2003) Predictive factors for the absence of cellular rejection after liver transplantation in a protocol biopsy population. In: HEPATOLOGY. (pp. 379A - 379A). W B SAUNDERS CO

Chakrabarti, S; Mackinnon, S; (2003) The relevance of nonmyeloablative transplants in developing countries: Lessons from the UK experience. In: TRANSPLANTATION PROCEEDINGS. (pp. 172 - 173). ELSEVIER SCIENCE INC

Chakrabarti, S; Milligan, DW; Pillay, D; Mackinnon, S; Holder, K; Kaur, N; McDonald, D; (2003) Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation. BLOOD , 102 (3) 839 - 842.

Chakraborty, R; Rees, G; Bourboulia, D; Cross, AM; Dixon, JR; D'Agostino, A; Musoke, R; (2003) Viral coinfections among African children infected with human immunodeficiency virus type 1. CLIN INFECT DIS , 36 (7) 922 - 924.

Chantret, I; Dancourt, J; Dupré, T; Delenda, C; Bucher, S; Vuillaumier-Barrot, S; Ogier de Baulny, H; (2003) A deficiency in dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolichyl alpha3-glucosyltransferase defines a new subtype of congenital disorders of glycosylation. J Biol Chem , 278 (11) pp. 9962-9971. 10.1074/jbc.M211950200. Gold open access

Chelvatheebam, S; Langabeer, SE; Linch, DC; Hills, RK; Greenwell, P; (2003) Incidence and prognostic significance of C-MPL expression in acute myeloid leukemia. LEUKEMIA RES , 27 (9) 869 - 870. 10.1016/S0145-2126(03)00016-X.

Chuang, SS; Lee, C; Hamoudi, RA; Liu, H; Lee, PS; Ye, H; Diss, TC; (2003) High frequency of t(11;18) in gastric mucosa-associated lymphoid tissue lymphomas in Taiwan, including one patient with high-grade transformation. Br J Haematol , 120 (1) pp. 97-100.

Ciocchetta, F; Dell'Anna, R; Demichelis, F; Dhillon, AP; Quaglia, A; Sboner, A; (2003) Combining supervised and unsupervised methods to support early diagnosis of hepatocellular carcinoma. In: Dojat, M and Keravnou, E and Barahona, P, (eds.) ARTIFICIAL INTELLIGENCE IN MEDICINE, PROCEEDINGS. (pp. 239 - 243). SPRINGER-VERLAG BERLIN

Ciocchetta, F; Dell'Anna, R; Demichelis, F; Sboner, A; Dhillon, AP; Dhillon, A; Godfrey, A; (2003) Knowledge discovery in support of early diagnosis of hepatocelluar carcinoma. In: PROCEEDINGS OF THE INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS 2003, VOLS 1-4. (pp. 177 - 181). IEEE

Clark, J; Edwards, S; Feber, A; Flohr, P; John, M; Giddings, I; Crossland, S; (2003) Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays. ONCOGENE , 22 (8) 1247 - 1252. 10.1038/sj.onc.1206247.

Coeytaux, E; Coulaud, D; Le Cam, E; Danos, O; Kichler, A; (2003) The cationic amphipathic alpha-helix of HIV-1 viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells. J Biol Chem , 278 (20) pp. 18110-18116. 10.1074/jbc.M300248200. Gold open access

Corsini, E; Viviani, B; Zancanella, O; Lucchi, L; Visioli, F; Serrero, G; Bartesaghi, S; (2003) Induction of adipose differentiation related protein and neutral lipid droplet accumulation in keratinocytes by skin irritants. J INVEST DERMATOL , 121 (2) 337 - 344.

Cox, ST; McWhinnie, AJ; Robinson, J; Marsh, SGE; Parham, P; Madrigal, JA; Little, AM; (2003) Cloning and sequencing full-length HLA-B and -C genes. TISSUE ANTIGENS , 61 (1) pp. 20-48. 10.1034/j.1399-0039.2003.610103.x.

Craig, CEH; Quaglia, A; Savage, K; Lowdell, MW; Selden, C; Sim, R; North, J; (2003) Hepatocyte progenitor cells in massive hepatic necrosis. In: JOURNAL OF PATHOLOGY. (pp. 2A - 2A). JOHN WILEY & SONS LTD

Craig, CEH; Quaglia, A; Savage, K; Lowdell, MW; Seldon, C; Sim, R; North, J; (2003) Hepatocyte progenitor cells in massive hepatic necrosis. In: (pp. 109-).

Craig, CEH; Quaglia, A; Savage, K; Lowdell, MW; Seldon, C; Sim, R; North, J; (2003) Hepatocyte progenitor cells in massive hepatic necrosis. JOURNAL OF HEPATOLOGY , 38 38 - 38.

Crowley, J; Hagan, R; Clancy, D; Rooney, G; Dunne, C; Lawlor, E; Hayden, P; (2003) Two sets of HLA class II DRB and DQB1 alleles co-segregate among family members in a single maternal haplotype. Antigens , 61 pp. 487-491.

D

D'Sa, S; Kyriakou, C; Bhattacharya, S; Peggs, K; Foulkes, B; Ings, S; Watts, M; (2003) Etoposide, methylprednisolone, cytarabine and cisplatin (ESHAP) can cytoreduce resistant myeloma patients and mobilise them for transplant without adverse effects. In: BLOOD. (pp. 688A - 688A). AMER SOC HEMATOLOGY

D'Sa, S; Peggs, K; Pizzey, A; Verfuerth, S; Thuraisundaram, D; Watts, M; White, H; (2003) T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions. British Journal of Haematology , 123 (2) pp. 309-322. 10.1046/j.1365-2141.2003.04612.x.

D'Sa, S; Peggs, K; Pizzey, A; Verfuerth, S; Thuraisundaram, D; Watts, M; White, H; (2003) T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions. BRIT J HAEMATOL , 123 (2) 309 - 322.

Davies, JK; Lowdell, MW; (2003) New advances in acute graft-versus-host disease prophylaxis. TRANSFUSION MED , 13 (6) 387 - 397.

Dittrich, C; Dumez, H; Calvert, H; Hanauske, A; Faber, M; Wanders, J; Yule, M; (2003) Phase I and pharmacokinetic study of E7070, a chloroindolyl-sulfonamide anticancer agent, administered on a weekly schedule to patients with solid tumors. CLIN CANCER RES , 9 (14) 5195 - 5204.

Dogan, A; Attygalle, AD; Kyriakou, C; (2003) Angioimmunoblastic T-cell lymphoma. BRITISH JOURNAL OF HAEMATOLOGY , 121 (5) pp. 681-691. 10.1046/j.1365-2141.2003.04335.x.

Donev, R; Horton, R; Beck, S; Doneva, T; Vatcheva, R; Bowen, WR; Sheer, D; (2003) Recruitment of heterogeneous nuclear ribonucleoprotein A1 in vivo to the LMP/TAP region of the major histocompatibility complex. J BIOL CHEM , 278 (7) 5214 - 5226. 10.1074/jbc.M206621200. Gold open access

Douar, AM; Poulard, K; Danos, O; (2003) Deleterious effect of peptide insertions in a permissive site of the AAV2 capsid. Virology , 309 (2) pp. 203-208.

Dudderidge, TJ; (2003) Urinary markers in bladder cancer. BJU INT , 92 (7) 823 - 824.

Dudderidge, TJ; Arya, M; Young, J; Davies, AJ; (2003) Stop those anti-platelet drugs before surgery! BJU Int , 92 (6) pp. 654-655.

Dupuis, S; Jouanguy, E; Al-Hajjar, S; Fieschi, C; Al-Mohsen, IZ; Al-Jumaah, S; Yang, K; (2003) Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet , 33 (3) pp. 388-391. 10.1038/ng1097.

de Bruin, EC; Meersma, D; de Wilde, J; den Otter, I; Schipper, EM; Medema, JP; Peltenburg, LT; (2003) A serine protease is involved in the initiation of DNA damage-induced apoptosis. Cell Death Differ , 10 (10) pp. 1204-1212. 10.1038/sj.cdd.4401296.

E

El Hamidi, A; Kocjan, G; Du, MQ; (2003) Clonality analysis of archival cervical smears - Correlation of monoclonality with grade and clinical behavior of cervical intraepithelial neoplasia. ACTA CYTOL , 47 (2) 117 - 123.

F

Fallen, PR; Duarte, RF; McGreavey, L; Potter, M; Ethell, M; Prentice, HG; Madrigal, JA; (2003) Identification of non-naive CD4(+) CD45RA(+) T cell subsets in adult allogeneic haematopoietic cell transplant recipients. BONE MARROW TRANSPL , 32 (6) 609 - 616. 10.1038/sj.bmt.1704185.

Fallen, PR; Duarte, RF; McGreavey, L; Potter, M; Ethell, M; Prentice, HG; Madrigal, JA; (2003) Identification of non-naive CD4(+) CD45RA(+) T cell subsets in adult allogeneic haematopoietic cell transplant recipients. BONE MARROW TRANSPLANTATION , 32 (6) pp. 609-616.

Fallen, PR; McGreavey, L; Madrigal, JA; Potter, M; Ethell, M; Prentice, HG; Guimaraes, A; (2003) Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. BONE MARROW TRANSPL , 32 (10) 1001 - 1014. 10.1038/sj.bmt.1704235.

Fallen, PR; McGreavey, L; Madrigal, JA; Potter, M; Ethell, M; Prentice, HG; Guimaraes, A; (2003) Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. BONE MARROW TRANSPLANTATION , 32 (10) pp. 1001-1014.

Field, N; Low, W; Daniels, M; Howell, S; Daviet, L; Boshoff, C; Collins, M; (2003) KSHV vFLIP binds to IKK-gamma to activate IKK. J CELL SCI , 116 (18) 3721 - 3728. 10.1242/jcs.00691.

Fields, PA; Cohen, H; Patterson, KG; (2003) Splenunculectomy in autoimmune thrombocytopenic purpura. Br J Haematol , 123 (3) 377-.

Flanagan, AM; Massey, HM; (2003) Generating human osteoclasts in vitro from bone marrow and peripheral blood. Methods Mol Med , 80 pp. 113-128. 10.1385/1-59259-366-6:113.

Flanagan, J; Healey, S; Young, J; Whitehall, V; Chenevix-Trench, G; (2003) Analysis of the transcription regulator, CNOT7, as a candidate chromosome 8 tumour suppressor gene in colorectal cancer. International Journal of Cancer , 106 (4) pp. 505-509.

Flynn, AA; Pedley, RB; Green, AJ; Dearling, JL; El-Emir, E; Boxer, GM; Boden, R; (2003) The nonuniformity of antibody distribution in the kidney and its influence on dosimetry. Radiat Res , 159 (2) pp. 182-189.

Folarin, NI; Baker, RJ; Lowdell, MW; Wickremasinghe, RG; Marks, AJ; Hoffbrand, AV; Mehra, AB; (2003) ZAP-70 detecting by flow cytometry in cells from chronic lymphocytic leukaemia patients using a highly fluorescent Alexa Flour dye. In: BLOOD. (pp. 347B - 348B). AMER SOC HEMATOLOGY

Forshew, T; Johnson, CA; Willis, C; Moore, AT; Maher, ER; (2003) Mapping of an autosomal recessive congenital cataract locus to chromosome 9q. In: AMERICAN JOURNAL OF HUMAN GENETICS. (pp. 489 - 489). UNIV CHICAGO PRESS

Forshew, T; Johnson, CA; Willis, C; Moore, AT; Maher, ER; (2003) Mapping of an autosomal recessive congenital cataract locus to chromosome 9q. In: JOURNAL OF MEDICAL GENETICS. (pp. S86 - S86). B M J PUBLISHING GROUP

Francis, DL; Freeman, A; Visvikis, D; Costa, DC; Luthra, SK; Novelli, M; Taylor, I; (2003) In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography. Gut , 52 (11) pp. 1602-1606.

Fricke, B; Argent, AC; Chetty, MC; Pizzey, AR; Turner, EJ; Ho, MM; Lolascon, A; (2003) The "stomatin" gene and protein in overhydrated hereditary stomatocytosis. BLOOD , 102 (6) 2268 - 2277. 10.1182/blood-2002-06-1705.

Fricke, B; Stewart, GW; Treharne, KJ; Mehta, A; Knopfle, G; Friedrichs, N; Muller, KM; (2003) Stomatin immunoreactivity in ciliated cells of the human airway epithelium. ANAT EMBRYOL , 207 (1) 1 - 7. 10.1007/s00429-003-0324-7.

Frleta, D; Lin, JT; Quezada, SA; Wade, TK; Barth, RJ; Noelle, RJ; Wade, WF; (2003) Distinctive maturation of in vitro versus in vivo anti-CD40 mAb-matured dendritic cells in mice. J IMMUNOTHER , 26 (1) 72 - 84.

G

Gaffan, J; Holden, L; Newlands, ES; Short, D; Fuller, S; Begent, RHJ; Rustin, GJS; (2003) Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours - a retrospective long-term follow-up study. BRIT J CANCER , 89 (10) 1849 - 1854. 10.1038/sj.bjc.6601383.

Gale, RE; (2003) Pathogenic markers in essential thrombocythemia. Curr Hematol Rep , 2 (3) pp. 242-247.

Ganeshaguru, K; Jones, DT; Folarin, NI; Marks, AJ; Addison, E; North, JM; Lowdell, MW; (2003) Ansamysins synergise with conventional drugs in apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. In: BLOOD. (pp. 349B - 349B). AMER SOC HEMATOLOGY

Garcia, CA; Robinson, J; Guethlein, LA; Parham, P; Madrigal, JA; Marsh, SGE; (2003) Human KIR sequences 2003. IMMUNOGENETICS , 55 (4) pp. 227-239. 10.1007/s00251-003-0572-y.

Garcia, CA; Robinson, J; Madrigal, JA; Marsh, SGE; (2003) Natural killer cell receptors: Functional roles. Inmunologia , 22 (2) pp. 190-202.

Gardiner, C; Pennaneac'h, C; Mackie, IJ; Sheldrake, A; Harrison, J; Machin, SJ; (2003) Falsely elevated D-dimer results in a healthy patient on account of heterophiletul antibodies. BRIT J HAEMATOL , 122 (5) 871 - 873.

Geddes, JF; Tasker, RC; Hackshaw, AK; Nickols, CD; Adams, GGW; Whitwell, HL; Scheimberg, I; (2003) Dural haemorrhage in non-traumatic infant deaths: does it explain the bleeding in 'shaken baby syndrome'? NEUROPATH APPL NEURO , 29 (1) 14 - 22.

Gerrard, G; Ganeshaguru, G; Payne, B; Baker, R; McCullough, H; Jones, DT; Potter, M; (2003) Inhibition of P-gp activity in AML patients treated with zosuquidar trihydrochloride. In: (Proceedings) 5th International Symposium on Leukemia and Lymphoma. (pp. p. 665). NATURE PUBLISHING GROUP

Ginhoux, F; Doucet, C; Leboeuf, M; Lemonnier, FA; Danos, O; Davoust, J; Firat, H; (2003) Identification of an HLA-A*0201-restricted epitopic peptide from human dystrophin: application in duchenne muscular dystrophy gene therapy. Mol Ther , 8 (2) pp. 274-283.

Godfrey, A; Laman, H; Boshoff, C; (2003) RNA interference: a potential tool against Kaposi's sarcoma-associated herpesvirus. CURR OPIN INFECT DIS , 16 (6) 593 - 600. 10.1097/01.qco.0000104301.87920.4a.

Gribble, SM; Reid, AG; Bench, AJ; Huntly, BJP; Grace, C; Green, AR; Nacheva, EP; (2003) Molecular cytogenetics of polycythaemia vera: lack of occult rearrangements detectable by 20q LSP screening, CGH, and M-FISH. In: LEUKEMIA. (pp. 1419 - 1421). NATURE PUBLISHING GROUP

Gribble, SM; Reid, AG; Roberts, I; Grace, C; Green, AR; Nacheva, EP; (2003) Genomic imbalances in CML blast crisis: 8q24.12-q24.13 segment identified as a common region of over- representation. GENE CHROMOSOME CANC , 37 (4) 346 - 358.

Grimshaw, GM; Szczepura, A; Hultén, M; MacDonald, F; Nevin, NC; Sutton, F; Dhanjal, S; (2003) Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities. Health Technol Assess , 7 (10) pp. 1-146.

Gross, DA; Leboeuf, M; Gjata, B; Danos, O; Davoust, J; (2003) CD4+CD25+ regulatory T cells inhibit immune-mediated transgene rejection. Blood , 102 (13) pp. 4326-4328. 10.1182/blood-2003-05-1454.

Grote, D; Cattaneo, R; Fielding, AK; (2003) Neutrophils contribute to the measles virus-induced antitumor effect: Enhancement by granulocyte macrophage colony-stimulating factor expression. CANCER RES , 63 (19) 6463 - 6468.

H

Hackshaw, AK; Paul, EA; (2003) Breast self-examination and death from breast cancer: a meta-analysis. BRIT J CANCER , 88 (7) 1047 - 1053. 10.1038/sj.bjc.6600847.

Hadjur, S; Jirik, FR; (2003) Increased sensitivity of Fancc-deficient hematopoietic cells to nitric oxide and evidence that this species mediates growth inhibition by cytokines. BLOOD , 101 (10) 3877 - 3884.

Hammond, KL; Loynes, HE; Folarin, AA; Smith, J; Whitfield, TT; (2003) Hedgehog signalling is required for correct anteroposterior patterning of the zebrafish otic vesicle. DEVELOPMENT , 130 (7) 1403 - 1417. 10.1242/dev.00360.

Harrison, CJ; Mazzullo, H; Cheung, KL; Gerrard, G; Jalali, GR; Mehta, A; Osier, DG; (2003) Cytogenetics of multiple myeloma: Interpretation of fluorescence in situ hybridization results. British Journal of Haematology , 120 (6) pp. 944-952. 10.1046/j.1365-2141.2003.04172.x.

Harrison, CJ; Mazzullo, H; Cheung, KL; Gerrard, G; Jalali, GR; Mehta, A; Osier, DG; (2003) Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results. BRIT J HAEMATOL , 120 (6) 944 - 952.

Hergovich, A; Lisztwan, J; Barry, R; Ballschmieter, P; Krek, W; (2003) Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. NAT CELL BIOL , 5 (1) 64 - 70. 10.1038/ncb899.

Herrero, J; Al-Shahrour, F; Diaz-Uriarte, R; Mateos, A; Vaquerizas, JM; Santoyo, J; Dopazo, J; (2003) GEPAS: a web-based resource for microarray gene expression data analysis. NUCLEIC ACIDS RESEARCH , 31 (13) pp. 3461-3467. 10.1093/nar/gkg591.

Herrero, J; Diaz-Uriarte, R; Dopazo, J; (2003) An approach to inferring transcriptional regulation among genes from large-scale expression data. COMPARATIVE AND FUNCTIONAL GENOMICS , 4 (1) pp. 148-154. 10.1002/cfg.237. Gold open access

Herrero, J; Díaz-Uriarte, R; Dopazo, J; (2003) Gene expression data preprocessing. Bioinformatics , 19 (5) pp. 655-656.

Hewison, M; Freeman, L; Hughes, SV; Evans, KN; Bland, R; Eliopoulos, AG; Kilby, MD; (2003) Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J IMMUNOL , 170 (11) 5382 - 5390.

Horton, MA; Massey, HM; Rosenberg, N; Nicholls, B; Seligsohn, U; Flanagan, AM; (2003) Upregulation of osteoclast alpha 2 beta 1 integrin compensates for lack of alpha v beta 3 vitronectin receptor in Iraqi-Jewish-type Glanzmann thrombasthenia. BRIT J HAEMATOL , 122 (6) 950 - 957.

Horton, R; Beck, S; (2003) Accessing HLA sequencing data through the 6ace database. Methods Mol Biol , 210 pp. 23-42.

Hughes, SE; (2003) Detection of apoptosis by in situ markers for DNA strand breaks in the failing human heart. Fact or epiphenomenon. The Journal of Pathology (201) pp. 181-186.

Hulten, MA; Dhanjal, S; Pertl, B; (2003) Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCR. REPRODUCTION , 126 (3) 279 - 297.

Huntly, BJP; Guilhot, F; Reid, AG; Vassiliou, G; Hennig, E; Franke, C; Byrne, J; (2003) Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions. In: BLOOD. (pp. 2205 - 2212). AMER SOC HEMATOLOGY

J

Jarvis, M; Marzolini, M; Wang, XN; Jackson, G; Sviland, L; Dickinson, AM; (2003) Heat shock protein 70: correlation of expression with degree of graft-versus-host response and clinical graft-versus-host disease. Transplantation , 76 (5) pp. 849-853. 10.1097/01.TP.0000083556.73555.78.

Jenner, RG; Maillard, K; Cattini, N; Weiss, RA; Boshoff, C; Wooster, R; Kellam, P; (2003) Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a gene expression profile. P NATL ACAD SCI USA , 100 (18) 10399 - 10404. 10.1073/pnas.1630810100.

Jones, DT; Ganeshaguru, K; Anderson, RJ; Jackson, TR; Bruckdorfer, KR; Low, SY; Palmqvist, L; (2003) Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. BLOOD , 101 (8) 3174 - 3180. 10.1182/blood-2002-07-2143.

Jones, DT; Ganeshaguru, K; Anderson, RJ; Jackson, TR; Bruckdorfer, KR; Low, SY; Palmqvist, L; (2003) Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. Blood , 101 (8) pp. 3174-3180. 10.1182/blood-2002-07-2143.

Jones, DT; Ganeshaguru, K; Mitchell, WA; Foroni, L; Baker, RJ; Prentice, HG; Mehta, AB; (2003) Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand. BRIT J HAEMATOL , 121 (5) 713 - 720.

Jones, DT; Ganeshaguru, K; Mitchell, WA; Foroni, L; Baker, RJ; Prentice, HG; Mehta, AB; (2003) Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand. Br J Haematol , 121 (5) pp. 713-720.

Joshi, C; Enver, T; (2003) Molecular complexities of stem cells. CURRENT OPINION IN HEMATOLOGY , 10 (3) pp. 220-228. 10.1097/00062752-200305000-00005.

K

Karzynski, M; Mateos, A; Herrero, J; Dopazo, J; (2003) Using a genetic algorithm and a perceptron for feature selection and supervised class learning in DNA microarray data. Artificial Intelligence Review , 20 (1-2) pp. 39-51. 10.1023/A:1026032530166.

Kauppila, S; Maaty, WS; Chen, P; Tomar, RS; Eby, MT; Chapo, J; Chew, S; (2003) Eiger and its receptor, Wengen, comprise a TNF-like system in Drosophila. Oncogene , 22 (31) pp. 4860-4867. 10.1038/sj.onc.1206715.

Kellam, P; Holzerlandt, R; Gramoustianou, E; Jenner, R; Kwan, A; (2003) Viral bioinformatics: computational views of host and pathogen. Novartis Found Symp , 254 pp. 234-247.

Kerr, DJ; McArdle, CS; Ledermann, J; Taylor, I; Sherlock, DJ; Schlag, PM; Buckels, J; (2003) Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. LANCET , 361 (9355) 368 - 373.

Khan, K; Kostoula, V; Savage, K; Stubbs, M; McStay, M; Dhillon, AP; Caplin, ME; (2003) Expression of c-kit (CD117) in neuroendocrine tumours - A target for therapy? In: (pp. 333-).

Khan, K; Kostoula, V; Savage, K; Stubbs, M; McStay, M; Dhillon, AP; Caplin, ME; (2003) Expression of c-kit (CD117) in neuroendocrine tumours - A target for therapy? In: GUT. (pp. A91 - A91). BRITISH MED JOURNAL PUBL GROUP

Kibe, T; Tomita, K; Matsuura, A; Izawa, D; Kodaira, T; Ushimaru, T; Uritani, M; (2003) Fission yeast Rhp51 is required for the maintenance of telomere structure in the absence of the Ku heterodimer. Nucleic Acids Res , 31 (17) pp. 5054-5063. Gold open access

Kichler, A; Leborgne, C; März, J; Danos, O; Bechinger, B; (2003) Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells. Proc Natl Acad Sci U S A , 100 (4) pp. 1564-1568. 10.1073/pnas.0337677100.

Kichler, A; Sabourault, N; Décor, R; Leborgne, C; Schmutz, M; Valleix, A; Danos, O; (2003) Preparation and evaluation of a new class of gene transfer reagents: poly(-alkylaminosiloxanes). J Control Release , 93 (3) pp. 403-414.

Kocjan, G; (2003) Fine needle aspiration cytology. Cytopathology , 14 (6) pp. 307-308.

Kostoula, V; Khan, K; Savage, K; Hochhauser, D; Stubbs, M; McStay, M; Dhillon, AP; (2003) Expression of c-kit (cd117) in neuroendocrine tumours - a target for therapy? ENDOCR-RELAT CANCER , 10 (4) 508 - 508.

Kottaridis, PD; Gale, RE; Linch, DC; (2003) FLT3 mutations and leukaemia. BRIT J HAEMATOL , 122 (4) 523 - 538.

Kottaridis, PD; Gale, RE; Linch, DC; (2003) Prognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemia. LEUKEMIA LYMPHOMA , 44 (6) 905 - 913. 10.1080/1024819031000067503.

Kyriacou, C; Kottaridis, PD; Eliahoo, J; Mckeag, N; Bomford, J; McGarrigle, HH; Linch, DC; (2003) Germ cell damage and Leydig cell insufficiency in recipients of nonmyeloablative transplantation for haematological malignancies. BONE MARROW TRANSPL , 31 (1) 45 - 50. 10.1038/sj.bmt.1703777.

L

Lacombe, D; Butler-Smith, A; Therasse, P; Fumoleau, P; Burtles, S; Calvert, H; Marsoni, S; (2003) Cancer drug development in Europe: A selection of new agents under development at the European Drug Development Network. CANCER INVEST , 21 (1) 137 - 147. 10.1081/CNV-120016408.

Laderach, D; Compagno, D; Danos, O; Vainchenker, W; Galy, A; (2003) RNA interference shows critical requirement for NF-kappa B p50 in the production of IL-12 by human dendritic cells. J Immunol , 171 (4) pp. 1750-1757.

Lambert, S; Mason, SJ; Barber, LJ; Hartley, JA; Pearce, JA; Carr, AM; McHugh, PJ; (2003) Schizosaccharomyces pombe checkpoint response to DNA interstrand cross-links. MOL CELL BIOL , 23 (13) 4728 - 4737.

Lawrie, AS; Gray, E; Leeming, D; Davidson, SJ; Purdy, G; Iampietro, R; Craig, S; (2003) A multicentre assessment of the endogenous thrombin potential using a continuous monitoring amidolytic technique. BRIT J HAEMATOL , 123 (2) 335 - 341.

Lea, NC; Orr, SJ; Stoeber, K; Williams, GH; Lam, EWF; Ibrahim, MAA; Mufti, GJ; (2003) Commitment point during G(0)-> G(1) that controls entry into the cell cycle. MOL CELL BIOL , 23 (7) 2351 - 2361. 10.1128/MCB.23.7.2351-2361.2003.

Lee, AC; Chicken, DW; Pickard, CDO; Briggs, GM; Kocjan, G; Falzon, M; Bigio, I; (2003) Comparative study of elastic scattering spectroscopy and touch imprint cytology in assessing sentinel lymph node status in breast cancer. In: BRITISH JOURNAL OF SURGERY. (pp. 112 - 112). JOHN WILEY & SONS LTD

Lee, AC; Pickard, CDO; Briggs, GM; Sainsbury, JR; Falzon, M; Kocjan, G; Bigio, I; (2003) Intra-operative assessment by optical biopsy for sentinel lymph node metastasis in breast cancer: update and comparison with imprint cytology. BRITISH JOURNAL OF SURGERY , 90 (5) 625 - 626.

Lee, YC; Flora, R; McCafferty, JA; Gor, J; Tsaneva, IR; Perkins, SJ; (2003) A tetramer-octamer equilibrium in Mycobacterium leprae and Escherichia coli RuvA by analytical ultracentrifugation. J MOL BIOL , 333 (4) 677 - 682. 10.1016/j.jmb.2003.08.047.

Leonard, P; Sharp, T; Henderson, S; Hewitt, D; Pringle, J; Sandison, A; Goodship, A; (2003) Gene expression array profile of human osteosarcoma. BRIT J CANCER , 89 (12) 2284 - 2288. 10.1038/sj.bjc.6601389.

Leverrier, Y; Okkenhaug, K; Sawyer, C; Bilancio, A; Vanhaesebroeck, B; Ridley, AJ; (2003) Class I phosphoinositide 3-kinase p110 beta is required for apoptotic cell and Fc gamma receptor-mediated phagocytosis by macrophages. JOURNAL OF BIOLOGICAL CHEMISTRY , 278 (40) pp. 38437-38442. 10.1074/jbc.M306649200. Gold open access

LoRusso, PM; Herbst, RS; Rischin, D; Ranson, M; Calvert, H; Raymond, E; Kieback, D; (2003) Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors. CLIN CANCER RES , 9 (6) 2040 - 2048.

Lowdell, MW; (2003) Natural killer cells in haematopoietic stem cell transplantation. TRANSFUSION MED , 13 (6) 399 - 404.

M

Mackie, IJ; Kitchen, S; Machin, SJ; Lowe, GDO; Brit Comm Stand Haematology, ; (2003) Guidelines on fibrinogen assays. BRIT J HAEMATOL , 121 (3) 396 - 404.

Madrigal, JA; Garcia, CA; Gutierrez, ME; Shaw, BE; Arguello, A; Little, AM; March, SGE; (2003) El complejo mayor de histocompatibilidad y su papel biologico. HLA y su papel en la evolucion clinica de transplantes y enfermedades autoinmunes. In: Garcia-Conde, JJ and San Migual, JF and Sierra, J and Urbano-Ispizua, A and Vicente, V and Vives Corrons, JL, (eds.) Hematologia. (pp. 105-112). Aran Edcines: Madrid.

Maffucci, T; Brancaccio, A; Piccolo, E; Stein, RC; Falasca, M; (2003) Insulin induces phosphatidylinositol-3-phosphate formation through TC10 activation. EMBO JOURNAL , 22 (16) pp. 4178-4189. 10.1093/emboj/cdg402.

Maiers, M; Schreuder, GMT; Lau, M; Marsh, SGE; Fernandez-Vina, M; Noreen, H; Setterholm, M; (2003) Use of a neural network to assign serologic specificities to HLA-A, -B and -DRB1 allelic products. TISSUE ANTIGENS , 62 (1) pp. 21-47. 10.1034/j.1399-0039.2003.00097.x.

Marafioti, T; Ascani, S; Pulford, K; Sabattini, E; Piccioli, M; Jones, M; Zinzani, PL; (2003) Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. Am J Pathol , 162 (3) pp. 861-871. 10.1016/S0002-9440(10)63882-5.

Marafioti, T; Jabri, L; Pulford, K; Brousset, P; Mason, DY; Delsol, G; (2003) Leucocyte-specific protein (LSP1) in malignant lymphoma and Hodgkin's disease. Br J Haematol , 120 (4) pp. 671-678.

Marafioti, T; Jones, M; Facchetti, F; Diss, TC; Du, MQ; Isaacson, PG; Pozzobon, M; (2003) Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. Blood , 102 (8) pp. 2868-2876. 10.1182/blood-2003-03-0692.

Marden, CM; North, J; Little, A; Madrigal, JA; Lowdell, MW; (2003) In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. Blood , 102 (11) 964-.

Marks, AJ; Cooper, M; Orchard, K; Folarin, NI; Ganeshaguru, K; Hoffbrand, AV; Mehta, AB; (2003) Targeted therapy with an amphipathic peptide results in selective apoptotic cell death in CD19 positive chronic lymphocytic leukemia cells. In: BLOOD. (pp. 73A - 74A). AMER SOC HEMATOLOGY

Marsh, SG; (2003) HLA nomenclature and the IMGT/HLA sequence database. In: UNSPECIFIED (pp. 165-173).

Marsh, SG; (2003) Nomenclature for factors of the HLA system, update June 2003. Hum Immunol , 64 (9) pp. 919-920.

Marsh, SG; (2003) Nomenclature for factors of the HLA system, update May 2003. Hum Immunol , 64 (9) pp. 917-918.

Marsh, SG; (2003) Nomenclature for factors of the HLA system, update September 2003. Eur J Immunogenet , 30 (6) 437-.

Marsh, SG; Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update February 2003. Hum Immunol , 64 (6) pp. 656-657.

Marsh, SG; Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update January 2003. Hum Immunol , 64 (6) 655-.

Marsh, SG; Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, updated August 2002. Hum Immunol , 64 (1) pp. 180-181.

Marsh, SG; Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, updated July 2002. Hum Immunol , 64 (1) 179-.

Marsh, SG; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Hum Immunol , 64 (6) pp. 648-654.

Marsh, SG; WHO Nomenclature Commitee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update February 2003. Eur J Immunogenet , 30 (3) 237-.

Marsh, SG; WHO Nomenclature Commitee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update January 2003. Eur J Immunogenet , 30 (3) 235-.

Marsh, SG; WHO Nomenclature Commitee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update March 2003. Eur J Immunogenet , 30 (3) 239-.

Marsh, SG; WHO Nomenclature Committee Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update February 2003. Tissue Antigens , 62 (1) pp. 89-90.

Marsh, SG; WHO Nomenclature Committee Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update January 2003. Tissue Antigens , 62 (1) pp. 87-88.

Marsh, SG; WHO Nomenclature Committee Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update March 2003. Tissue Antigens , 62 (1) pp. 91-92.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update April 2003. Eur J Immunogenet , 30 (4) pp. 299-300.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update April 2003. Tissue Antigens , 62 (4) pp. 333-334.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update August 2002. Eur J Immunogenet , 30 (1) 91-.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update December 2002. Tissue Antigens , 61 (5) pp. 412-413.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update December 2002. Eur J Immunogenet , 30 (2) 167-.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update July 2002. Eur J Immunogenet , 30 (1) 89-.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update June 2003. Eur J Immunogenet , 30 (4) pp. 303-304.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update June 2003. Tissue Antigens , 62 (4) pp. 337-338.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update May 2003. Tissue Antigens , 62 (4) pp. 335-336.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update May 2003. Eur J Immunogenet , 30 (4) 301-.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update November 2002. Eur J Immunogenet , 30 (2) pp. 165-166.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update November 2002. Tissue Antigens , 61 (5) pp. 410-411.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update October 2002. Eur J Immunogenet , 30 (1) 95-.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update October 2002. Tissue Antigens , 61 (5) pp. 408-409.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update September 2002. Eur J Immunogenet , 30 (1) pp. 93-94.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update, April 2003. Hum Immunol , 64 (8) pp. 835-836.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, update, September 2002. Hum Immunol , 64 (5) pp. 572-573.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, updated August 2003. Hum Immunol , 64 (12) 1197-.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2003) Nomenclature for factors of the HLA system, updated July 2003. Hum Immunol , 64 (12) pp. 1195-1196.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. EUROPEAN JOURNAL OF IMMUNOGENETICS , 30 (3) pp. 229-234. 10.1046/j.1365-2370.2003.00383.x.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. IMMUNOGENETICS , 55 (4) pp. 220-226. 10.1007/s00251-003-0571-z.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. TISSUE ANTIGENS , 62 (1) pp. 79-86. 10.1034/j.1399-0039.2003.00072.x.

Martin, F; Chowdhury, S; Neil, SJ; Chester, KA; Cosset, FL; Collins, MK; (2003) Targeted retroviral infection of tumor cells by receptor cooperation. J VIROL , 77 (4) 2753 - 2756. 10.1128/JVI.77.4.2753-2756.2003.

Martin, M; Spielmann, M; Namer, M; duBois, A; Unger, C; Dodwell, D; Vodvarka, P; (2003) Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines. ANN ONCOL , 14 (8) 1246 - 1252. 10.1093/annonc/mdg339.

Martin, MJ; Herrero, J; Mateos, A; Dopazo, J; (2003) Comparing bacterial genomes through conservation profiles. Genome Res , 13 (5) pp. 991-998. 10.1101/gr.678303.

Martino, R; Giralt, S; Caballero, MD; Mackinnon, S; Corradini, P; Fernandez-Aviles, F; San Miguel, J; (2003) Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study. HAEMATOLOGICA , 88 (5) 555 - 560. Gold open access

Mason, C; Markusen, JF; Boshoff, CH; (2003) Methods employing cells derived from adult bone marrow.

Maughan, TS; James, RD; Kerr, DJ; Ledermann, JA; Seymour, MT; Topham, C; McArdle, C; (2003) Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial. LANCET , 361 (9356) 457 - 464.

Mayer, A; Tsiompanou, E; Flynn, AA; Pedley, RB; Dearling, J; Boden, R; Begent, RHJ; (2003) Higher dose and dose-rate in smaller tumors result in improved tumor control. CANCER INVEST , 21 (3) 382 - 388. 10.1081/CNV-120018229.

Mayer, A.; Tsiompanou, E.; Flynn, A.A; Pedley, R.B.; Dearling, J.; Boden, R.; Begent, R.H.J.; (2003) Higher dose and dose-rate in smaller tumors result in improved tumor control. Cancer Investigation , 21 (3) pp. 382-388. 10.1081/CNV-120018229.

McGregor, L; Makela, V; Darling, SM; Vrontou, S; Chalepakis, G; Roberts, C; Smart, N; (2003) Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix protein. NAT GENET , 34 (2) 203 - 208.

McStay, M; Savage, K; Khan, K; Stubbs, M; Dhillon, AP; Caplin, M; (2003) Expression of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP receptor in the continuum from benign to malignant liver nodules. In: GASTROENTEROLOGY. (pp. A565 - A565). W B SAUNDERS CO

Mela, M; Raimondo, ML; Quaglia, A; Dhillon, AP; Rolles, K; Davidson, B; Patch, D; (2003) Randomised trial of tacrolimus monotherapy versus tacrolimus/prednisolone/azathioprine in liver transplantation for HCV cirrhosis: Early rejection rates. Journal of Hepatology , 38 129-.

Mela, M; Raimondo, ML; Quaglia, A; Dhillon, AP; Rolles, K; Davidson, B; Patch, D; (2003) Randomised trial of tacrolimus monotherapy versus tacrolimus/prednisolone/azathioprine in liver transplantation for HCV cirrhosis: Early rejection rates. In: (pp. 129-).

Meyer, T; McTiernan, A; Whelan, J; (2003) A Phase II Study of Docetaxel in Patients with Relapsed and Refractory Ewing's Tumours. Sarcoma , 7 (1) pp. 13-17. 10.1080/1357714031000114192. Gold open access

Mitsiadis, TA; Angeli, I; James, C; Lendahl, U; Sharpe, PT; (2003) Role of Islet1 in the patterning of murine dentition. Development , 130 (18) pp. 4451-4460.

Moon, JCC; Sachdev, B; Elkington, AG; McKenna, WJ; Mehta, A; Pennell, DJ; Leed, PJ; (2003) Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease - Evidence for a disease specific abnormality of the myocardial interstitium. EUR HEART J , 24 (23) 2151 - 2155. 10.1016/j.ehj.2003.09.017.

Morris, EC; Rebello, P; Thomson, KJ; Peggs, KS; Kyrialkou, C; Goldstone, AH; Mackinnon, S; (2003) Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications. BLOOD , 102 (1) 404 - 406.

Mumford, AD; McVey, JH; Morse, CV; Gomez, K; Steen, M; Norstrom, EA; Tuddenham, EG; (2003) Factor V I359T: a novel mutation associated with thrombosis and resistance to activated protein C. Br J Haematol , 123 (3) pp. 496-501.

Mungall, AJ; Palmer, SA; Sims, SK; Edwards, CA; Ashurst, JL; Wilming, L; Jones, MC; (2003) The DNA sequence and analysis of human chromosome 6. NATURE , 425 (6960) 805 - U1. 10.1038/nature02055.

Mörner, A; Thomas, JA; Björling, E; Munson, PJ; Lucas, SB; McKnight, A; (2003) Productive HIV-2 infection in the brain is restricted to macrophages/microglia. AIDS , 17 (10) pp. 1451-1455. 10.1097/01.aids.0000076269.76134.c7.

N

Nash, MJ; Camilleri, RS; Liesner, R; Mackie, IJ; Machin, SJ; Cohen, H; (2003) Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (Beta2GPI) polymorphism and anti-Beta2GPI antibodies. BRIT J HAEMATOL , 120 (3) 529 - 531.

Newman, G; (2003) ICON4/AGO-OVAR-2.2: questions about trial design, cost-effectiveness, and clinical benefit. Lancet , 362 (9392) 1333-. 10.1016/S0140-6736(03)14602-8.

Newton, R; Ziegler, J; Ateenyi-Agaba, C; Bousarghin, L; Casabonne, D; Beral, V; Mbidde, E; (2003) The epidemiology of conjunctival squamous cell carcinoma in Uganda (vol 87, pg 301, 2002). BRIT J CANCER , 89 (2) 423 - 423. 10.1038/sj.bjc.6601128.

Newton, R; Ziegler, J; Bourboulia, D; Casabonne, D; Beral, V; Mbidde, E; Carpenter, L; (2003) Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda. BRIT J CANCER , 89 (3) 502 - 504. 10.1038/sj.bjc.6601113.

Newton, R; Ziegler, J; Bourboulia, D; Casaborne, D; Beral, V; Mbidde, E; Carpenter, L; (2003) The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda. INT J CANCER , 103 (2) 226 - 232. 10.1002/ijc.10817.

Nikitenko, LL; Smith, DM; Bicknell, R; Rees, MCP; (2003) Transcriptional regulation of the CRLR gene in human microvascular endothelial cells by hypoxia. FASEB J , 17 (9) 1499 - +. 10.1096/fj.02-0993fje.

Novelli, M; Cossu, A; Oukrif, D; Quaglia, A; Lakhani, S; Poulsom, R; Sasieni, P; (2003) X-inactivation patch size in human female tissue confounds the assessment of tumor clonality. P NATL ACAD SCI USA , 100 (6) 3311 - 3314. 10.1073/pnas.0437825100.

O

O'Connor, DL; Jacobs, J; Hall, R; Adamkin, D; Auestad, N; Castillo, M; Connor, WE; (2003) Growth and development of premature infants fed predominantly human milk, predominantly premature infant formula, or a combination of human milk and premature formula. J Pediatr Gastroenterol Nutr , 37 (4) pp. 437-446.

Okkenhaug, K; Vanhaesebroeck, B; (2003) PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol , 3 (4) pp. 317-330. 10.1038/nri1056.

Okkenhaug, K; Vanhaesebroeck, B; (2003) PI3K-signalling in B- and T-cells: insights from gene-targeted mice. BIOCHEMICAL SOCIETY TRANSACTIONS , 31 pp. 270-274.

Ono, Y; Tomita, K; Matsuura, A; Nakagawa, T; Masukata, H; Uritani, M; Ushimaru, T; (2003) A novel allele of fission yeast rad11 that causes defects in DNA repair and telomere length regulation. Nucleic Acids Res , 31 (24) pp. 7141-7149. Gold open access

Orleans-Lindsay, JK; Deru, A; Craig, JIO; Prentice, HG; Lowdell, MW; (2003) In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic cells; a strategy for ex-vivo generation of CTL for immunotherapy. CLIN EXP IMMUNOL , 133 (3) 467 - 475.

Otth, C; Mendoza-Naranjo, A; Mujica, L; Zambrano, A; Concha, II; Maccioni, RB; (2003) Modulation of the JNK and p38 pathways by cdk5 protein kinase in a transgenic mouse model of Alzheimer's disease. NEUROREPORT , 14 (18) 2403 - 2409. 10.1097/01.wnr.0000099988.54721.3c.

P

Pamphilon, DH; Lowdell, MW; (2003) Stem cells and immunotherapy. TRANSFUSION MED , 13 (6) 323 - 324.

Parmar, M.K.; Ledermann, J.A.; Colombo, N.; du Bois, A.; Delaloye, J.F.; (2003) Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. The Lancet , 361 (9375) pp. 2099-2106. 10.1016/S0140-6736(03)13718-X.

Parmar, MKB; Ledermann, JA; Colombo, N; du Bois, A; Delaloye, JF; Kristensen, GB; Wheeler, S; (2003) Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. LANCET , 361 (9375) 2099 - 2106.

Paston, SJ; Dodi, IA; Travers, PJ; Madrigal, JA; (2003) The role of HLA-B alleles in CMV peptide epitope presentation. Is there a hierarchy in HLA presentation of CMV epitopes: 14th Annual BSHI conference abstracts. EUR J IMMUNOGEN , 30 (4) pp. 305-323.

Peggs, K; Mackinnon, S; (2003) Imatinib mesylate - The new gold standard for treatment of chronic myeloid leukemia. NEW ENGL J MED , 348 (11) 1048 - 1050.

Peggs, K.S.; Mackinnon, S.; Williams, C.D.; D'Sa, S.; Thuraisundaram, D.; Kyriakou, C.; Morris, E.C.; (2003) Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity. Biology of Blood and Marrow Transplantation , 9 (4) pp. 257-265. 10.1053/bbmt.2003.50009.

Peggs, KS; Banerjee, L; Thomson, K; Mackinnon, S; (2003) Post-transplant lymphoproliferative disorders following reduced intensity conditioning with in vivo T cell depletion. BONE MARROW TRANSPL , 31 (8) 725 - 726. 10.1038/sj.bmt.1703893.

Peggs, KS; Mackinnon, S; Williams, CD; D'Sa, S; Thuraisundaram, D; Kyriakou, C; Morris, EC; (2003) Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: Limited efficacy of graft-versus-tumor activity. BIOL BLOOD MARROW TR , 9 (4) 257 - 265. 10.1053/bbmt.2003.50009.

Peggs, KS; Verfuerth, S; D'Sa, S; Yong, K; Mackinnon, S; (2003) Assessing diversity: immune reconstitution and T-cell receptor BV spectratype analysis following stem cell transplantation. BRIT J HAEMATOL , 120 (1) 154 - 165.

Peggs, KS; Verfuerth, S; Pizzey, A; Khan, N; Guiver, M; Moss, PA; Mackinnon, S; (2003) Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. LANCET , 362 (9393) 1375 - 1377.

Peggs, KS; Verfuerth, S; Pizzey, A; Khan, N; Moss, P; Goldstone, AH; Yong, K; (2003) Reconstitution of T-cell repertoire after autologous stem cell transplantation: Influence of CD34 selection and cytomegalovirus infection. BIOL BLOOD MARROW TR , 9 (3) 198 - 205. 10.1053/bbmt.2003.50010.

Pepys, M.B.; Bybee, A.; Booth, D.R.; Bishop, M.T.; Will, R.G.; Little, A.-M; Prokupek, B.; (2003) MHC typing in variant Creutzfeldt-Jakob disease. The Lancet , 361 (9356) pp. 487-489. 10.1016/S0140-6736(03)12455-5.

Pepys, MB; Bybee, A; Booth, DR; Bishop, MT; Will, RG; Little, AM; Prokupek, B; (2003) MHC typing in variant Creutzfeldt-Jakob disease. LANCET , 361 (9356) pp. 487-489.

Pepys, MB; Bybee, A; Booth, DR; Bishop, MT; Will, RG; Little, AM; Prokupek, B; (2003) MHC typing in variant Creutzfeldt-Jakob disease. LANCET , 361 (9356) 487 - 489.

Pileri, SA; Gaidano, G; Zinzani, PL; Falini, B; Gaulard, P; Zucca, E; Pieri, F; (2003) Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. Am J Pathol , 162 (1) pp. 243-253.

Pileri, SA; Marafioti, T; Pozzobon, M; Sabattini, E; Ascani, S; Mancini, C; Piccioli, M; (2003) The different expression of key-molecules allows the easy subclassification of Hodgkin's lymphoma cases as well as their distinction from non-Hodgkin's lymphomas. Pathologica , 95 (5) 227-.

Plummer, R; Rees, C; Hughes, A; Beale, P; Highley, M; Trigo, J; Gokul, S; (2003) A phase I trial of ZD9331, a water-soluble, nonpolyglutamatable, thymidylate synthase inhibitor. CLIN CANCER RES , 9 (4) 1313 - 1322.

Pollara, G; Speidel, K; Samady, L; Rajpopat, M; McGrath, Y; Ledermann, J; Coffin, RS; (2003) Herpes simplex virus infection of dendritic cells: Balance among activation, inhibition, and immunity. J INFECT DIS , 187 (2) 165 - 178.

Porakishvili, N; Slovick, A; Jewell, AP; Youinou, PY; Nathwani, A; Yong, K; Stevenson, F; (2003) Activation of B-CLL cells by anti CD180 monoclonal antibodies: Responder and non-responder patients. In: BLOOD. (pp. 432A - 432A). AMER SOC HEMATOLOGY

Poulsom, R; Campbell, V; Jeffery, R; Hunt, T; Alison, MR; Dhillon, AP; Quaglia, AF; (2003) Hepatocytes bearing the Philadelphia chromosome: Evidence for transdifferentiation of bone marrow to liver without transplantation. In: JOURNAL OF PATHOLOGY. (pp. 4A - 4A). JOHN WILEY & SONS LTD

Poulsom, R; Campbell, V; Jeffery, R; Hunt, T; Alison, MR; Quaglia, A; Dhillon, AP; (2003) Hepatocytes bearing the Philadelphia chromosome reveal transdifferentiation of bone marrow to liver without transplantation. In: (pp. 205-).

Powles, T; Thirlwell, C; Nelson, M; Bower, M; (2003) Immune reconstitution inflammatory syndrome mimicking relapse of AIDS related lymphoma in patients with HIV 1 infection. LEUKEMIA LYMPHOMA , 44 (8) 1417 - 1419. 10.1080/1042819031000083280.

Pratten, J; Pasu, M; Jackson, G; Flanagan, A; Wilson, M; (2003) Modetting oral malodour in a longitudinal study. ARCH ORAL BIOL , 48 (11) 737 - 743. 10.1016/S0003-9969(03)00154-7.

Preiser, W; Brink, NS; Ayliffe, U; Peggs, KS; Mackinnon, S; Tedder, RS; Garson, JA; (2003) Development and clinical application of a fully controlled quantitative PCR assay for cell-free cytomegalovirus in human plasma. J CLIN VIROL , 26 (1) 49 - 59.

Presneau, N; Manderson, EN; Tonin, PN; (2003) The quest for a tumor suppressor gene phenotype. CURR MOL MED , 3 (7) 605 - 629.

Presneau, N; Mes-Masson, AM; Ge, B; Provencher, D; Hudson, TJ; Tonin, PN; (2003) Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines. ONCOGENE , 22 (10) 1568 - 1579. 10.1038/sj.onc.1206219.

Q

Quaglia, A; Jutand, MA; Dhillon, A; Godfrey, A; Colombari, R; Togni, R; Dalla Palma, P; (2003) A novel algorithm for the histological assessment of hepatocellular carcinoma and its putative precursor nodular lesions in cirrhotic liver. In: JOURNAL OF PATHOLOGY. (pp. 21A - 21A). JOHN WILEY & SONS LTD

Quaglia, A; Tibballs, J; Grasso, A; Prasad, N; Nozza, P; Davies, SE; Burroughs, AK; (2003) Focal nodular hyperplasia-like areas in cirrhosis. HISTOPATHOLOGY , 42 (1) 14 - 21.

Quezada, SA; Eckert, M; Adeyi, OA; Schned, AR; Noelle, RJ; Burns, CM; (2003) Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis. ARTHRITIS RHEUM , 48 (9) 2541 - 2554. 10.1002/art.11230.

Quezada, SA; Fuller, B; Jarvinen, LZ; Gonzalez, M; Blazar, BR; Rudensky, AY; Strom, TB; (2003) Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation. BLOOD , 102 (5) 1920 - 1926. 10.1182/blood-2003-02-0586.

R

Reid, AG; Huntly, BJP; Grace, C; Green, AR; Nacheva, EP; (2003) Survival implications of molecular heterogeneity in variant Philadelphia-positive chronic myeloid leukaemia. BRIT J HAEMATOL , 121 (3) 419 - 427.

Reid, AG; Swanton, S; Grace, C; Campbell, LJ; Green, AR; Nacheva, EP; (2003) Double Philadelphia masquerading as chromosome 20q deletion - a new recurrent abnormality in chronic myeloid leukaemia blast crisis. In: BRIT J HAEMATOL. (pp. 442 - 448). BLACKWELL PUBLISHING LTD

Reid, AG; Tarpey, PS; Nacheva, EP; (2003) High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes. GENE CHROMOSOME CANC , 37 (3) 282 - 290. 10.1002/gcc.10215.

Reigner, B; Watanabe, T; Schuller, J; Lucraft, H; Sasaki, Y; Bridgewater, J; Saeki, T; (2003) Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer. CANCER CHEMOTHERAPY AND PHARMACOLOGY , 52 (3) pp. 193-201. 10.1007/s00280-003-0642-8.

Roberts, C; Robinson, J; Dodi, IS; Madrigal, JA; Marsh, SGE; (2003) The European Searchable Tumour Cell Line Database (ESTDAB). In: (pp. 321-).

Robinson, J; Marsh, SG; (2003) HLA informatics. Accessing HLA sequences from sequence databases. In: UNSPECIFIED (pp. 3-21).

Robinson, J; Waller, MJ; Parham, P; de Groot, N; Bontrop, R; Kennedy, LJ; Stoehr, P; (2003) IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. NUCLEIC ACIDS RESEARCH , 31 (1) pp. 311-314. 10.1093/nar/GKG070. Gold open access

Rolfe, KJ; MacLean, AB; Crow, JC; Benjamin, E; Reid, WMN; Perrett, CW; (2003) TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva. BRIT J CANCER , 89 (12) 2249 - 2253. 10.1038/sj.bjc.6601444.

Rotta, G; Edwards, EW; Sangaletti, S; Bennett, C; Ronzoni, S; Colombo, MP; Steinman, RM; (2003) Lipopolysaccharide or whole bacteria block the conversion of inflammatory monocytes into dendritic cells in vivo. JOURNAL OF EXPERIMENTAL MEDICINE , 198 (8) pp. 1253-1263. 10.1084/jem.20030335.

Rozman, P; Karas, M; Kosir, A; Madrigal, JA; Middleton, D; Navarette, C; Oudshoorn, M; (2003) Are human platelet alloantigens (HPA) minor transplantation antigens in clinical bone marrow transplantation antigens in clinical bone marrow transplantation? BONE MARROW TRANSPLANTATION , 31 pp. 497-506.

S

Saravanamuthu, J; Reid, WMN; St George, D; Crow, JC; Rolfe, KJ; MacLean, AB; Perrett, CW; (2003) The role of angiogenesis in vulvar cancer, vulvar intraepithelial neoplasia, and vulvar lichen sclerosus as determined by microvessel density analysis. GYNECOL ONCOL , 89 (2) 251 - 258. 10.1016/S0090-8258(03)00055-6.

Sarker, D; Thirlwell, C; Nelson, M; Gazzard, B; Bower, M; (2003) Leptomeningeal disease in AIDS-related non-Hodgkin's lymphoma. AIDS , 17 (6) 861 - 865. 10.1097/01.aids.0000050863.71999.f8.

Sawyer, C; Sturge, J; Bennett, DC; O'Hare, MJ; Allen, WE; Bain, J; Jones, GE; (2003) Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110 delta. CANCER RESEARCH , 63 (7) pp. 1667-1675.

Sayle, KL; Bentley, J; Boyle, FT; Calvert, AH; Cheng, YZ; Curtin, NJ; Endicott, JA; (2003) Structure-based design of 2-arylamino-4-cyclohexylmethyl-5-nitroso-6-aminopyrimidine inhibitors of cyclin-dependent kinases 1 and 2. BIOORG MED CHEM LETT , 13 (18) 3079 - 3082. 10.1016/S0960-894X(03)00651-6.

Schraml, P; Hergovich, A; Hatz, F; Amin, MB; Lim, SD; Krek, W; Mihatsch, MJ; (2003) Relevance of nuclear and cytoplasmic von hippel lindau protein expression for renal carcinoma progression. Am J Pathol , 163 (3) pp. 1013-1020.

Sebastiani, G; Wallace, DF; Lioumi, M; Goutos, I; Mitchell, WA; Bomford, AB; Dhillon, AP; (2003) Non HFE-related haemochromatosis: exclusion of the 1q21 zinc-iron regulated transporter-like (ZIRTL) gene in juvenile haemochromatosis. J HEPATOL , 38 (3) 376 - 377. 10.1016/S0168-8278(02)00426-9.

Seldon, C; Chalmers, SA; Jones, C; Standish, R; Quaglia, A; Rolando, N; Burroughs, AK; (2003) Epithelial colonies cultured from human explanted liver in subacute hepatic failure exhibit hepatocyte, biliary epithelial, and stem cell phenotypic markers. STEM CELLS , 21 (6) 624 - 631.

Sen, S; Jalan, R; Morris, EC; Steiner, C; Mackinnon, S; Williams, R; (2003) Reversal of severe cholestasis caused by chronic graft-versus-host disease with the MARS liver-support device. TRANSPLANTATION , 75 (10) 1766 - 1767. 10.1097/01.TP.0000062538.32752.C1.

Shaw, B; Smith, C; Potter, M; Mayor, N; Marsh, SGE; Madrigal, JA; (2003) TNF Alpha promoter polymorphism may exhibit may exhibit recombination and have an impact on engraftment in unrelated donor HSCT. In: (pp. S51-).

Shaw, BE; Peggs, K; Bird, JM; Cavenagh, J; Hunter, A; Alejandro Madrigal, J; Russell, NH; (2003) The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma. Br J Haematol , 123 (5) pp. 886-895.

Shaw, BE; Peggs, K; Bird, JM; Cavenaugh, J; Hunter, A; Madrigal, JA; Russell, NH; (2003) The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma. BRIT J HAEMATOLOGY, BR J HAEMATOL , 123 pp. 886-895.

Shaw, BE; Potter, MN; Mayor, NP; Pay, AL; Smith, C; Goldman, JM; Prentice, HG; (2003) The degree of matching at HLA-DPB1 predicts for acute graft- versus-host disease and disease relapse following haematopoietic stem cell transplantation. Bone Marrow Transplantation , 31 (11) pp. 1001-1008.

Shaw, BE; Potter, MN; Mayor, NP; Pay, AL; Smith, C; Goldman, JM; Prentice, HG; (2003) The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation. BONE MARROW TRANSPL , 31 (11) 1001 - 1008. 10.1038/sj.bmt.1704029.

Shaw, BE; Potter, MN; Mayor, NP; Pay, AL; Smith, C; Goldman, JM; Prentice, HG; (2003) The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation. Bone Marrow Transplantation , 31 (11) pp. 1001-1008. 10.1038/sj.bmt.1704029.

Sieben, NLG; Kolkman-Uljee, SM; Flanagan, AM; le Cessie, S; Cleton-Jansen, AM; Cornelisse, CJ; Fleuren, GJ; (2003) Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors. AMERICAN JOURNAL OF PATHOLOGY , 162 (4) pp. 1095-1101. 10.1016/S0002-9440(10)63906-5.

Simpson, P; Gale, T; Reis, J; Jones, C; Mackay, A; Bulmer, K; Jones, A; (2003) 14-3-3 sigma is a selective myoepithelial cell marker also expressed in basaloid/myoepithelial breast tumours. In: JOURNAL OF PATHOLOGY. (pp. 34A - 34A). JOHN WILEY & SONS LTD

Sinclair, N; Mireskandari, K; Forbes, J; Crow, J; (2003) Merkel cell carcinoma of the eyelid in association with chronic lymphocytic leukaemia. BRITISH JOURNAL OF OPHTHALMOLOGY , 87 (2) p. 240. 10.1136/bjo.87.2.240.

Skalitzky, DJ; Marakovits, JT; Maegley, KA; Ekker, A; Yu, XH; Hostomsky, Z; Webber, SE; (2003) Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors. J MED CHEM , 46 (2) 210 - 213. 10.1021/jm0255769.

Smellie, M; Bose, DS; Thompson, AS; Jenkins, TC; Hartley, JA; Thurston, DE; (2003) Sequence-selective recognition of duplex DNA through covalent interstrand cross-linking: Kinetic and molecular modeling studies with pyrrolobenzodiazepine dimers. BIOCHEMISTRY-US , 42 (27) 8232 - 8239. 10.1021/bi034313t.

Smith, L; Lowdell, MW; (2003) Quality issues in stem cell and immunotherapy laboratories. TRANSFUSION MED , 13 (6) 417 - 423.

Somervaille, TCP; Linch, DC; Khwaja, A; (2003) Different levels of p38 MAP kinase activity mediate distinct biological effects in primary human erythroid progenitors. BRIT J HAEMATOL , 120 (5) 876 - 886.

Starke, R; Harrison, P; Drummond, O; Macgregor, I; Mackie, I; Machin, S; (2003) The majority of cellular prion protein released from endothelial cells is soluble. TRANSFUSION , 43 (5) 677 - 678.

Starke, R; Harrison, P; Drummond, O; Macgregor, I; Mackie, I; Machin, S; Simak, J; (2003) The majority of cellular prion protein released from endothelial cells is soluble [1] (multiple letters). Transfusion , 43 (5) pp. 677-678. 10.1046/j.1537-2995.2003.00405.x.

Starke, R; Harrison, P; Gale, R; Mackie, I; Drummond, O; MacGregor, I; Machin, S; (2003) Endothelial cells express normal cellular prion protein. BRIT J HAEMATOL , 123 (2) 372 - 373.

Stebbing, J; Bourboulia, D; Johnson, M; Henderson, S; Williams, I; Wilder, N; Tyrer, M; (2003) Kaposi's sarcoma-associated herpesvirus cytotoxic T lymphocytes recognize and target Darwinian positively selected autologous K1 epitopes. J VIROL , 77 (7) 4306 - 4314. 10.1128/JVI.77.7.4306-4314.2003.

Stebbing, J; Wildfire, A; Portsmouth, S; Powles, T; Thirlwell, C; Hewitt, P; Nelson, M; (2003) Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations. ANN ONCOL , 14 (11) 1660 - 1666. 10.1093/annonc/mdg461.

Strauss, SJ; Marples, M; Napier, MP; Meyer, T; Boxall, J; Rustin, GJ; (2003) A phase I (tumour site-specific) study of carboplatin and temozolomide in patients with advanced melanoma. Br J Cancer , 89 (10) pp. 1901-1905. 10.1038/sj.bjc.6601414.

Strauss, SJ; McTiernan, A; Driver, D; Hall-Craggs, M; Sandison, A; Cassoni, AM; Kilby, A; (2003) Single center experience of a new intensive induction therapy for Ewing's family of tumors: Feasibility, toxicity, and stem cell mobilization properties. Journal of Clinical Oncology , 21 (15) pp. 2974-2981. 10.1200/JCO.2003.04.106.

Strauss, SJ; McTiernan, A; Driver, D; Hall-Craggs, M; Sandison, A; Cassoni, AM; Kilby, A; (2003) Single center experience of a new intensive induction therapy for Ewing's family of tumors: Feasibility, toxicity, and stem cell mobilization properties. J CLIN ONCOL , 21 (15) 2974 - 2981. 10.1200/JCO.2003.04.106.

Stubbs, M; Khan, K; Savage, K; McStay, M; Dhillon, AP; Caplin, ME; (2003) CCK2 receptor as a therapeutic target for neuroendocrine tumours. In: (pp. 108-).

Stubbs, M; Khan, K; Savage, K; McStay, M; Dhillon, AP; Caplin, ME; (2003) CCK2 receptor as a therapeutic target for neuroendocrine tumours. ENDOCR-RELAT CANCER , 10 (4) 505 - 505.

Stubbs, M; Khan, K; Savage, K; McStay, M; Dhillon, AP; Caplin, ME; (2003) CCK2 receptor as a therapeutic target for neuroendocrine tumours. In: GUT. (pp. A29 - A30). BRITISH MED JOURNAL PUBL GROUP

Stubbs, M; Khan, K; Watson, SA; Grimes, S; Michaeli, D; Savage, K; McStay, M; (2003) Peptide targeting of CCK-2 receptor in hepatic and pancreatic tumour cell lines. In: GASTROENTEROLOGY. (pp. A305 - A305). W B SAUNDERS CO

Stubbs, M; Khan, K; Watson, SA; Grimes, S; Michaeli, D; Savage, K; McStay, M; (2003) Peptide targeting of CCK-2 receptor in tumour cell lines. GUT , 52 A52 - A52.

Sullivan, A; Uff, CR; Isacke, CM; Thorne, RF; (2003) PACE-1, a novel protein that interacts with the C-terminal domain of ezrin. Exp Cell Res , 284 (2) pp. 224-238.

T

Tatton, L; Morley, GM; Chopra, R; Khwaja, A; (2003) The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases. J BIOL CHEM , 278 (7) 4847 - 4853. 10.1074/jbc.M209321200. Gold open access

Taylor, RM; Cheeseman, P; Preedy, V; Baker, AJ; Grimble, G; (2003) Can energy expenditure be predicted in critically ill children?. Pediatr Crit Care Med , 4 (2) pp. 176-180. 10.1097/01.PCC.0000059425.09149.D8.

Thirlwell, C; Brock, CS; (2003) Emergencies in oncology. CLIN MED , 3 (4) 306 - 310.

Thirlwell, C; Sarker, D; Stebbing, J; Bower, M; (2003) Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy. CLIN LYMPHOMA , 4 (2) 86 - 92.

Tipping, AJ; Deininger, MW; Goldman, JM; Melo, JV; (2003) Comparative gene expression profile of chronic myeloid leukemia cells innately resistant to imatinib mesylate. EXP HEMATOL , 31 (11) 1073 - 1080. 10.1016/j.exphem.2003.08.006.

Tipping, AJ; Melo, JV; (2003) Imatinib mesylate in combination with other chemotherapeutic drugs: In vitro studies. SEMIN HEMATOL , 40 (2) 83 - 91. 10.1053/shem.2003.50047.

Tomita, K; Matsuura, A; Caspari, T; Carr, AM; Akamatsu, Y; Iwasaki, H; Mizuno, K; (2003) Competition between the Rad50 complex and the Ku heterodimer reveals a role for Exo1 in processing double-strand breaks but not telomeres. Mol Cell Biol , 23 (15) pp. 5186-5197.

Treurnicht, K; Danta, M; Dhillon, AP; (2003) Thyroid transcription factor (TTF)-1 immunostaining in hepatocellular carcinoma. In: JOURNAL OF PATHOLOGY. (pp. 21A - 21A). JOHN WILEY & SONS LTD

Tsotinis, A; Vlachou, M; Kiakos, K; Hartley, JA; Thurston, DE; (2003) Design and synthesis of two cytotoxic analogs of the novel pyrrolo[1 ',2 ': 1,2][1,4]diazepin [7,6-b]indol-5(6H)-one nucleus. CHEM LETT , 32 (6) 512 - 513. 10.1246/cl.2003.512.

Tucker, E; Buda, A; Janghra, N; Baker, J; Coad, J; Moorghan, M; Havler, M; (2003) Abnormalities of the cadherin-catenin complex in chemically-induced colo-rectal carcinogenesis. In: (Proceedings) 7th International Vahouny Fibre Symposium. (pp. pp. 229-236). C A B I PUBLISHING

Turner, MR; Warren, JD; Jacobs, JM; Groves, MJ; Yong, K; Honan, WP; Thomas, PK; (2003) Microvasculitic paraproteinaemic polyneuropathy and B-cell lymphoma. J PERIPHER NERV SYST , 8 (2) 100 - 107.

U

Ueno, M; Nakazaki, T; Akamatsu, Y; Watanabe, K; Tomita, K; Lindsay, HD; Shinagawa, H; (2003) Molecular characterization of the Schizosaccharomyces pombe nbs1+ gene involved in DNA repair and telomere maintenance. Mol Cell Biol , 23 (18) pp. 6553-6563.

Urbaniak, MD; Frost, LM; Bingham, JP; Kelland, LR; Hartley, JA; Woolfson, DN; Caddick, S; (2003) Chemical synthesis and cytotoxicity of dihydroxylated cyclopentenone analogues of neocarzinostatin chromophore. BIOORG MED CHEM LETT , 13 (12) 2025 - 2027. 10.1016/S0960-894X(03)00328-7.

V

Valovka, T; Verdier, F; Cramer, R; Zhyvoloup, A; Fenton, T; Rebholz, H; Wang, ML; (2003) Protein kinase C phosphorylates ribosomal protein S6 kinase beta II and regulates its subcellular localization. MOL CELL BIOL , 23 (3) 852 - 863. 10.1128/MCB.23.3.852-863.2003.

Viviani, B; Bartesaghi, S; Gardoni, F; Vezzani, A; Behrens, MM; Bartfai, T; Binaglia, M; (2003) Interleukin-1 beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J NEUROSCI , 23 (25) 8692 - 8700.

Volz, A; Ehlers, A; Younger, R; Forbes, S; Trowsdale, J; Schnorr, D; Beck, S; (2003) Complex transcription and splicing of odorant receptor genes. Journal of Biological Chemistry , 278 (22) 19691 - 19701. 10.1074/jbc.M212424200 .

W

Wald, N.J.; Huttly, W.J.; Hackshaw, A.K.; (2003) Antenatal screening for Down's syndrome with the quadruple test. The Lancet , 361 (9360) pp. 835-836. 10.1016/S0140-6736(03)12680-3.

Wald, NJ; Huttly, WJ; Hackshaw, AK; (2003) Antenatal screening for Down's syndrome with the quadruple test. LANCET , 361 (9360) 835 - 836.

Wald, NJ; Rish, S; Hackshaw, AK; (2003) Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies. PRENATAL DIAG , 23 (7) 588 - 592. 10.1002/pd.627.

Wald, NJ; Rodeck, C; Hackshaw, AK; Walters, J; Chitty, L; Mackinson, AM; (2003) First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J MED SCREEN , 10 (2) 56 - 104.

Wald, NJ; Rodeck, C; Hackshaw, AK; Walters, J; Chitty, L; Mackinson, AM; SURUSS Research Group, ; (2003) First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess , 7 (11) pp. 1-77.

Walmsley, MJ; Ooi, SKT; Reynolds, LF; Smith, SH; Ruf, S; Mathiot, A; Vanes, L; (2003) Critical roles for Rac1 and Rac2 GTPases in B cell development and signaling. SCIENCE , 302 (5644) 459 - 462.

Wells, P; Aboagye, E; Gunn, RN; Osman, S; Boddy, AV; Taylor, GA; Rafi, I; (2003) 2-[C-11]thymidine positron emission tomography as an indicator of thymidylate synthase inhibition in patients treated with AG337. J NATL CANCER I , 95 (9) 675 - 682.

Westbury, CB; Harrington, KJ; Rhys-Evans, P; Archer, DJ; Searle, AE; Henk, JM; Black, CM; (2003) Raynaud's phenomenon after radical radiotherapy for tumours of the head and neck. POSTGRAD MED J , 79 (929) 176 - 177.

Whelan, J; (2003) Where should teenagers with cancer be treated? Eur J Cancer , 39 (18) pp. 2573-2578.

Whiteway, A; Deru, W; Prentice, HG; Anderson, R; (2003) Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions. JOURNAL OF VIROLOGICAL METHODS , 114 (1) pp. 1-10. 10.1016/j.jviromet.2003.08.001.

Wilbourn, B; Harrison, P; Mackie, IJ; Liesner, R; Machin, SJ; (2003) Activation of platelets in whole blood by recombinant factor VIIa by a thrombin-dependent mechanism. BRIT J HAEMATOL , 122 (4) 651 - 661.

Wu, WS; Xu, ZX; Hittelman, WN; Salomoni, P; Pandolfi, PP; Chang, KS; (2003) Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappa B survival pathway. J BIOL CHEM , 278 (14) 12294 - 12304. 10.1074/jbc.M211849200. Gold open access

X

Xiao, B; Spencer, J; Clements, A; Ali-Khan, N; Mittnacht, S; Broceño, C; Burghammer, M; (2003) Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation. Proc Natl Acad Sci U S A , 100 (5) pp. 2363-2368. 10.1073/pnas.0436813100.

Y

Yarranton, H; Cohen, H; Pavord, SR; Benjamin, S; Hagger, D; Machin, SJ; (2003) Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura. BRIT J HAEMATOL , 121 (5) 778 - 785.

Yarranton, H; Lawrie, AS; Mackie, IJ; Machin, SJ; Pinkoski, L; Corash, L; (2003) Coagulation factor levels in cryosupernatant treated with amotosalen hydrochloride (S-59) and UVA light - a suitable plasma replacement in thrombotic thrombocytopenic purpura. In: BLOOD. (pp. 817A - 817A). AMER SOC HEMATOLOGY

Ye, HT; Liu, HX; Attygalle, A; Wotherspoon, AC; Nicholson, AG; Charlotte, F; Leblond, V; (2003) Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. BLOOD , 102 (3) pp. 1012-1018. 10.1182/blood-2002-11-3502.

Ye, HT; Liu, HX; Raderer, M; Choft, A; Ruskone-Fourmestraux, A; Wotherspoon, A; Dyer, MJS; (2003) High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma. BLOOD , 101 (7) pp. 2547-2550. 10.1182/blood-2002-10-3167.

Z

Zhyvoloup, A; Nemazanyy, I; Panasyuk, G; Valovka, T; Fenton, T; Rebholz, H; Wang, ML; (2003) Subcellular localization and regulation of coenzyme a synthase. J BIOL CHEM , 278 (50) 50316 - 50321. 10.1074/jbc.M307763200. Gold open access

Ziegler, J; Newton, R; Bourboulia, D; Casabonne, D; Beral, V; Mbidde, E; Carpenter, L; (2003) Risk factors for Kaposi's sarcoma: A case-control study of HIV-seronegative people in Uganda. INT J CANCER , 103 (2) 233 - 240. 10.1002/ijc.10818.

This list was generated on Sun Dec 4 06:33:25 2016 GMT.